Notes
including Asacol, Mezavant, Mezera, Pentasa, Salofalk and Teva-5 ASA.
Reference
Health Canada. Summary Safety Review - Mesalazine-containing products - Health Canada. Internet Document : 24 Sep 2020. Available from: URL: https://hpr-rps.hres.ca/reg-content/summary-safety-review-detail.php?lang=en&linkID=SSR00247
Rights and permissions
About this article
Cite this article
Health Canada review does not support mesalazine + birth defects link. Reactions Weekly 1825, 3 (2020). https://doi.org/10.1007/s40278-020-84243-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-84243-1